Quantitative MRI in muscular dystrophy: An indispensable trial endpoint?

Neurology. 2014 Sep 9;83(11):956-7. doi: 10.1212/WNL.0000000000000785. Epub 2014 Aug 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Humans
  • Leg*
  • Male
  • Muscle, Skeletal / drug effects*
  • Muscular Dystrophy, Duchenne / drug therapy*

Substances

  • Adrenal Cortex Hormones
  • Anti-Inflammatory Agents